Accelerate Identification of High-producing Cell Lines

Learn from Research BDS Scientist Lucie Grindes, BioReliance® End-to-End Solutions, about our mini-pool approach and how we can begin process development in parallel with cell line development.

Featured Resources

Guidebook: Break Down Roadblocks to Clinical SuccessThe key to this success is to make the right decisions at the right time. In this guidebook, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.

Case Study: Accelerate Time from DNA to MaterialLearn how our approach to mini pools allows us to deliver high-producing clones in an accelerated timeline, saving up to 3 months. In addition, we are able to begin process development in parallel with cell line development for clients with very challenging timelines.